Personalized Treatment Plans
496 articles
PARP Inhibitors for Pancreatic Cancer Maintenance Treatment
Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
Stereotactic Body Radiation Therapy (SBRT) for Select Pancreatic Cancer Patients
Stereotactic body radiation therapy (SBRT) is increasingly being used to treat locally advanced pancreatic cancer, and make it surgically removable.
Pancreatic Cancer and Drug Interactions: What You Need to Know
Pharmacist Trevor Christ emphasizes the importance of sharing your medication list with your medical team and pharmacist.
Support Groups Provide an Emotional Lift
Social worker Angie Heller knows the value of pancreatic cancer support groups. She leads a group at Columbia University Medical Center’s Pancreas Center.
PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations
A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.
Mental Health and Pancreatic Cancer
Dr. William Breitbart provides tips for your mental health during pancreatic cancer treatment, and an explanation of who can provide help.